The French government is moving to double annual medical deductible ceilings by decree, raising out-of-pocket caps to 200 euros while considering broader cuts to social security reimbursements.
Healthcare costs for millions of French citizens are once again in the political crosshairs. The government has announced plans to double the annual deductible ceilings on essential medical services by decree, a move designed to curb mounting public health expenditures but one that has immediately ignited fierce debate across the country.
Under the proposed regulatory changes, the maximum annual amount that social security beneficiaries must pay out of pocket for medications, paramedical acts, and medical transport is set to rise from 50 euros to 100 euros.
Simultaneously, the annual cap on flat-rate contributions for doctor consultations, radiology exams, and laboratory tests will also double from 50 euros to 100 euros. Combined, these shifts mean that the total maximum annual burden on patients relying on public healthcare will climb from 100 euros to 200 euros.
A Growing Out-of-Pocket Pressure
The proposed decree targets the foundational mechanisms of France’s Assurance Maladie, focusing on the non-reimbursable portions left directly to patients:
- Medication and Paramedical Acts: The individual deductible remains fixed at 1 euro per box of medication and 1 euro per paramedical service (such as physiotherapy or nursing care), but the annual ceiling constraining these deductions will double.
- Medical Transport: The 4-euro deductible per medical transport journey—excluding emergencies—will now accumulate much faster toward the newly elevated annual limit.
- Consultations and Diagnostics: The flat-rate contribution of 2 euros per doctor consultation, lab test, or medical imaging session will also see its cumulative yearly cap doubled.
While vulnerable groups, including minors, beneficiaries of the Complémentaire santé solidaire, and pregnant women, remain exempt from these hikes, the broader public faces an inevitable increase in healthcare costs at a time when household budgets are already stretched thin.
Broader Reforms on the Horizon
The decree on deductibles is only part of a broader, more contentious fiscal strategy. Government officials are reportedly still weighing an overall reduction in the baseline reimbursement rates provided by Social Security.
Such a move would shift a larger percentage of everyday healthcare costs onto patients and, by extension, private top-down insurance providers (mutuelles), likely triggering a rise in supplemental insurance premiums.
The administration defends the measures as an economic necessity, pointing to the widening deficit of the national health insurance system and the imperative to curb the growth of public spending.
However, critics, including healthcare worker unions and patient advocacy groups, argue that shifting the financial burden onto individuals penalises the sick and elderly, undermining the core principle of universal access embedded in the French social model.
As the decree moves toward formal implementation, the political fallout highlights the delicate balancing act facing policymakers: attempting to stabilise public finances while preserving a healthcare system that citizens have long viewed as a national sanctuary.
